Products for Research Use Only

Rheumatoid Factor Interference Blocker

CAT: 0952-A2010009Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0952-A2010009Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rheumatoid Factor Interference Blocker_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_
Catalog #A2010009
Size100 mg (also available in 1 g, 10 g and 100 g)
Other NamesRF Blocker
ContentProprietary blend of proteins and anti-RF antibodies
Concentration15-40 mg/mL
PurityAffinity purified
Storage2-8°C
Supplied asLiquid solution
KeywordsRheumatoid Factor, Interference,Rheumatoid factor interference immunoassays, Rheumatoid factor Elisa interference, Rheumatoid factor assay interference, Rheumatoid factor interference, rheumatoid factor interference blockers, rheumatoid factor interference kits
_x000D_ Download the Brochure_x000D_ _x000D_

_x000D_ References_x000D_
    _x000D_
  • Hollander, J. L. (1968). Rheumatoid Arthritis, Rheumatoid Factor, and Gamma G Globulin Fragments. Annals of Internal Medicine, 68(5), 1195.
  • _x000D_
  • Pappas, D. A., and Bathon, J. M. (2009). Treatment of Rheumatoid Arthritis: Tumor Necrosis Factor Inhibitors. Rheumatoid Arthritis, 337‚Äì349.
  • _x000D_
  • Shingu, M., Ezaki, I., and Nobunaga, M. (1988). Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor. Rheumatology International, 8(3), 95‚Äì100.
  • _x000D_
  • Vaughan, J. H. (1993). Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis and Rheumatism, 36(1), 1‚Äì6.
  • _x000D_
  • Xing Q, Fu L, Yu Z, Zhou X. Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta-Analysis. Evid Based Complement Alternat Med. 2020 Apr 2;2020:4348709.
  • _x000D_
  • Raine C, Austin K, Giles I. Mechanisms determining the amelioration of rheumatoid arthritis in pregnancy: A systematic review. Semin Arthritis Rheum. 2020 Mar 19. pii: S0049-0172(20)30079-2.
  • _x000D_
  • Toussirot E. The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition. Metabolites. 2020 Mar 13;10(3). pii: E107.
  • _x000D_
  • Ishikawa Y, Terao C. The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. Cells. 2020 Feb 19;9(2). pii: E475.
  • _x000D_
  • Carson DA, Chen PP, Kipps TJ. New roles for rheumatoid factor. J Clin Invest. 1991 Feb;87(2):379-83.
  • _x000D_
  • Hay FC, Jones MG, Bond A, Soltys AJ. Rheumatoid factors and complex formation. The role of light-chain framework sequences and glycosylation. Clin Orthop Relat Res. 1991 Apr;(265):54-62.
  • _x000D_
_x000D_ Related products to Rheumatoid Factor Interference Blocker_x000D_ _x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-interference-kit/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-human-plasma/_x000D_ _x000D_ https://moleculardepot.com/product/rheumatoid-factor-diluent/
Short Description
Catalog #: A2010009 (100 mg)
Weight
0.8
Length
2
Width
0.9
Height
0.9

Popular Products